UOC
ASPX

UBS O'Connor’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

UBS O'Connor’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-62,490
Closed -$6.27M – 1000
2015
Q1 		$6.27M Buy
+62,490
New +$4.16M 0.13% 191

UBS O'Connor's ASPX Position: Q2 2015 in Review

UBS O'Connor sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 62,490 shares — an estimated $6.27M sold.

UBS O'Connor first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $6.27M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • UBS O'Connor reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • UBS O'Connor sold 62,490 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $6.27M.
  • UBS O'Connor first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • UBS O'Connor's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $6.27M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on UBS O'Connor's 13F filing for Q2 2015, filed 13 Aug 2015.